Neuren Pharmaceuticals Limited ( NURPF) - Key Metrics

NURPF Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.26 $0.04 $0.06 $0.06
2025Q4 $0.29 $0.12 -$0.02 -$0.02
2025Q2 $0.22 $0.12 $0.99 $0.99
2024Q4 $1.47 $1.03 $0.07 $0.07
2024Q2 $0.19 $0.06 -$0.16 -$0.16

NURPF Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 113.19
2025Q4 0% 40.29
2025Q2 0% 27.89
2024Q4 0% 2.97
2024Q2 0% 85.16

NURPF Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.36% 0%
2025Q4 -0.12% 0%
2025Q2 7.43% 0%
2024Q4 0.58% 0%
2024Q2 -0.75% 0%

NURPF

Price: $14.28

52 week price:
7.70
17.25

Dividend Yield: 0.73%

Earnings Per Share: 0.11 USD

P/E Ratio: 146.36

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.8 billion

Links: